| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/29/2022 | 58.79% | Morgan Stanley | $20 → $21 | Maintains | Equal-Weight |
| 09/22/2022 | 66.35% | Cowen & Co. | → $22 | Initiates Coverage On | → Outperform |
| 09/07/2022 | 81.47% | Northland Capital Markets | → $24 | Initiates Coverage On | → Outperform |
| 08/18/2022 | 51.23% | Morgan Stanley | $13 → $20 | Maintains | Equal-Weight |
| 03/23/2022 | -1.7% | Morgan Stanley | → $13 | Initiates Coverage On | → Equal-Weight |
| 03/22/2022 | 20.98% | Guggenheim | → $16 | Initiates Coverage On | → Buy |
| 11/22/2021 | 164.65% | Wolfe Research | → $35 | Initiates Coverage On | → Outperform |
| 07/19/2021 | 164.65% | Susquehanna | → $35 | Initiates Coverage On | → Positive |
| 06/29/2021 | 262.95% | Credit Suisse | → $48 | Initiates Coverage On | → Outperform |
| 05/24/2021 | 126.84% | Goldman Sachs | → $30 | Initiates Coverage On | → Buy |
Stem Questions & Answers
The latest price target for Stem (NYSE: STEM) was reported by Morgan Stanley on September 29, 2022. The analyst firm set a price target for $21.00 expecting STEM to rise to within 12 months (a possible 58.79% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Stem (NYSE: STEM) was provided by Morgan Stanley, and Stem maintained their equal-weight rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Stem, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Stem was filed on September 29, 2022 so you should expect the next rating to be made available sometime around September 29, 2023.
While ratings are subjective and will change, the latest Stem (STEM) rating was a maintained with a price target of $20.00 to $21.00. The current price Stem (STEM) is trading at is $13.23, which is out of the analyst's predicted range.